A great deal of effort has been devoted during the past 20 years to defining the chemical nature of prions, the infectious agents responsible for transmissible spongiform encephalopathies. In contrast, much less attention has been paid to elucidating how prions actually damage the central nervous system. Although it is commonly assumed that PrP Sc , the protein constituent of infectious prions, is the primary culprit, increasing evidence indicates that this may not be the case. Several alternative molecular forms of PrP are reasonable candidates for the neurotoxic species in prion diseases, although it is still too early to tell whether these or other ones will turn out to be the true instigating factors. The cellular pathways activated by neurotoxic forms of PrP that ultimately result in neuronal death are also being investigated, and several possible mechanisms have been uncovered, including the operation of quality control processes in the endoplasmic reticulum. Elucidating the distinction between the infectious and neurotoxic forms of PrP has important implications for designing therapy of prion diseases, as well as for understanding pathogenic mechanisms operative in other neurodegenerative disorders and the role of prion-like states in biology.
INTRODUCTION
Prion diseases, also called transmissible spongiform encephalopathies, are fatal neurodegenerative disorders that have attracted enormous scientific attention because they exemplify a novel mechanism of biological information transfer based on the transmission of protein conformation rather than on the inheritance of nucleic acid sequence. These diseases have also had profound impact on public health because of compelling evidence that bovine spongiform encephalopathy (BSE), which reached epidemic proportions in Britain in the 1990s and is now increasing in other European countries as well, has been transmitted to about 100 human beings by consumption of contaminated beef. There is also great concern that these diseases could be acquired by blood transfusion or the administration of bloodderived products.
Many lines of evidence indicate that PrP
Sc , a conformationally altered isoform of the cellular protein PrP C , plays a key role in the origin of prion diseases (for comprehensive reviews, see Prusiner, 1998; Collinge, 2001) 
. Enciphered in the conformation of PrP
Sc is all the information necessary for propagation of the infectious agent (prion) and for specification of the clinical and neuropathological characteristics that distinguish different forms of prion diseases. A major gap exists, however, in our understanding of how the conformational conversion of PrP C into PrP Sc ultimately kills neurons and causes the other neuropathological features of these disorders. Many questions related to the pathogenic mechanisms underlying prion diseases remain unresolved. For example, is neuronal damage caused by a loss of the normal function of PrP C or by gain of a toxic property of PrP Sc ? Is PrP Sc the primary trigger of the neurodegenerative process, or are there neurotoxic PrP species other than PrP Sc ? What molec-
